COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk enters next chapter to bring better health to more people, supported by ‘Novo’ rebrand and updated corporate culture
14/09/2026
Bagsværd, Denmark, 14 September 2026 – Novo Nordisk marked the beginning of its next chapter today by unveiling a rebrand centred on ‘Lasting Health Starts Now’, and the single ‘Novo’ name, and by updating its culture [...]
Initiation of Novonesis’ share buyback program
14/09/2026
Today, Novonesis will initiate the first tranche (the “First Tranche”) of the EUR 1 billion multi-year share buyback program announced in Company Announcement No. 14, on August 19, 2026. Under the First Tranche, [...]
Bio Usawa and Axmed Partner to Expand Access to Affordable Biologic Medicines Across Africa
14/09/2026
Strategic collaboration combines African biologics capabilities with technology-enabled procurement, with an initial focus on retinal diseases KIGALI, Rwanda and BASEL, Switzerland, Sept. 14, 2026 (GLOBE NEWSWIRE) -- [...]
BioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patients
14/09/2026
Gotistobart continues to show potential as chemotherapy-free monotherapy to reignite anti-tumor immunity in previously treated patients with squamous non-small cell lung cancer, where median survival with current [...]
Johnson & Johnson’s RYBREVANT®▼ (amivantamab) plus chemotherapy delivers median overall survival of nearly three years in EGFR exon 20 insertion mutation-positive non-small cell lung cancer
14/09/2026
Amivantamab plus chemotherapy demonstrates durable benefit with a differentiated approach that dual targets EGFR and MET 1 Median overall survival reached 34.3 months with the amivantamab-based regimen, the longest [...]
Beverly Wilshire Aesthetics Beverly Hills Medical Spa Announces Global Rebrand, Expanding Botox, Dermal Fillers, and Morpheus8 Services
14/09/2026
BEVERLY HILLS, Calif., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Beverly Wilshire Aesthetics Medical Spa Beverly Hills is a leading full-service medical spa serving patients throughout Beverly Hills and the Los Angeles [...]
Basilea announces start of clinical study by partner Asahi Kasei Therapeutics in Japan with antifungal Cresemba® (isavuconazole) in pediatric patients
14/09/2026
Allschwil, Switzerland, September 14, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal [...]
MemoHoney Launch Advanced Brain Memory Support Capsules 2026 in USA: Read Memohoney Supplement Facts, Benefits and Ingredients Highlights.
13/09/2026
MemoHoney 2026 Announces a natural formula in the USA, designed to support brain health, memory and focus. Explore Memo Honey supplement facts, ingredients and key benefits. New York, Sept. 13, 2026 (GLOBE NEWSWIRE) -- [...]
Roche’s collaborator MediLink announces phase III data for Tam-Peli showing significantly improved overall survival in Chinese patient population with relapsed small-cell lung cancer
13/09/2026
Tambotatug pelitecan (Tam-Peli) demonstrated statistically significant efficacy over topotecan in a phase III study conducted in China, reducing the risk of death by 54% and disease progression by 71%, while achieving [...]
Zenbody RX Launches Telehealth Platform Built Around Personalized, Clinician-Guided GLP-1 Care
13/09/2026
The platform combines online access, individualized treatment, home delivery, and continued patient support in one connected care experience Winter Park, FL, Sept. 12, 2026 (GLOBE NEWSWIRE) -- Zenbody RX has launched [...]
Erica Zarkovich, Chief Market and Partnerships Officer, Named One of Canada’s Most Powerful Women: Top 100
11/09/2026
Toronto, Canada, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Erica Zar kovich, Chief Market and Partnerships Officer, has been named one of Canada’s Most Powerful Women: Top 100 by WXN Media in the CN Executive Leaders category [...]
Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity
11/09/2026
Virtual Webcast to be Held Monday, September 14, 2026, at 8:00 AM EDT NORWOOD, Mass., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on [...]
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
11/09/2026
CAMBRIDGE, Mass., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company leveraging a novel Oligonucleotide Promoted Editing of RNA (OPERA ® ) platform to develop a new [...]
Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley’s Ltd.)
11/09/2026
HOUSTON, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (the “ Company ”) today announced that the Company's Board of Directors has approved a 1 for 12.62 reverse stock split of the Company's issued and [...]
4DMT Announces New Employment Inducement Grants
11/09/2026
EMERYVILLE, Calif., Sept. 11, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
Agomab Announces Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
11/09/2026
Antwerp, Belgium, September 11, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab” or the “Company”), a clinical-stage biopharmaceutical company focused on fibro-inflammatory diseases, today announced that [...]
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/09/2026
ROCKVILLE, Md., Sept. 11, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engineering focused company providing enabling platform technologies to advance the discovery, development and [...]
Cellectis organise une conférence téléphonique et un webcast le 14 septembre pour présenter un point d’activité
11/09/2026
NEW YORK, 11 sept. 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS ; Nasdaq : CLLS), société de biotechnologie de stade clinique, qui utilise sa plateforme pionnière d'édition de génome pour développer des [...]
Cellectis to Host Conference Call and Webcast on September 14 to Provide a Business Update
11/09/2026
NEW YORK, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving [...]

Pages